Genetic contributions to transdiagnostic symptom dimensions in patients with major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders
Schizophrenia Research · 2023-02 · 252 · 161-171
DOI: 10.1016/j.schres.2023.01.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Schizophrenia Research, 2023-02. Verfasst von Friederike S David und 25 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Major Depressive Disorder, Bipolar Disorder, Schizophrenia. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Bundesministerium für Bildung und Forschung, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia spectrum disorders (SZ) exhibit considerable phenotypic and genetic overlap. However, the contribution of genetic factors to their shared psychopathological symptom dimensions remains unclear. The present exploratory study investigated genetic contributions to the symptom dimensions "Depression", "Negative syndrome", "Positive formal thought disorder", "Paranoid-hallucinatory syndrome", and "Increased appetite" in a transdiagnostic subset of the German FOR2107 cohort (n = 1042 patients with MDD, BD, or SZ). As replication cohort, a subset of the German/Austrian PsyCourse study (n = 816 patients with MDD, BD, or SZ) was employed. First, the relationship between symptom dimensions and common variants associated with MDD, BD, and SZ was investigated via polygenic risk score (PRS) association analyses, with disorder-specific PRS as predictors and symptom dimensions as outcomes. In the FOR2107 study sample, PRS for BD and SZ were positively associated with "Positive formal thought disorder", the PRS for SZ was positively associated with "Paranoid-hallucinatory syndrome", and the PRS for BD was negatively associated with "Depression". The effects of PRS for SZ were replicated in PsyCourse. No significant associations were observed for the MDD PRS. Second, genome-wide association studies (GWAS) were performed for the five symptom dimensions. No genome-wide significant associations and no replicable suggestive associations (p < 1e-6 in the GWAS) were identified. In summary, our results suggest that, similar to diagnostic categories, transdiagnostic psychiatric symptom dimensions are attributable to polygenic contributions with small effect sizes. Further studies in larger thoroughly phenotyped psychiatric cohorts are required to elucidate the genetic factors that shape psychopathological symptom dimensions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
- Department of Psychiatry and Psychotherapy, University of Marburg, Marburg, Germany; Center for Mind, Brain and Behavior, University of Marburg, Marburg, Germany.
- Department of Neurology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.
- Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany.
- Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany; Center for Innovative Psychiatry and Psychotherapy Research, Centr…
- Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany; Department of Biomedicine, University of Basel, Basel, Switzerland.
Förderung
- Bundesministerium für Bildung und Forschung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
David, F. S., Stein, F., Andlauer, T. F. M., Streit, F., Witt, S. H., Herms, S., Hoffmann, P., Heilmann-Heimbach, S., Opel, N., Repple, J., Jansen, A., Nenadić, I., Papiol, S., Heilbronner, U., Kalman, J. L., Schaupp, S. K., Senner, F., Schulte, E. C., Falkai, P. G., …, & Forstner, A. J. (2023). Genetic contributions to transdiagnostic symptom dimensions in patients with major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders. Schizophrenia Research, 252, 161-171. https://doi.org/10.1016/j.schres.2023.01.002
Vancouver
David FS, Stein F, Andlauer TFM, Streit F, Witt SH, Herms S, et al. Genetic contributions to transdiagnostic symptom dimensions in patients with major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders. Schizophrenia Research. 2023;252:161-171. doi:10.1016/j.schres.2023.01.002
BibTeX
@article{David2023,
author = {David, Friederike S and Stein, Frederike and Andlauer, Till F M and Streit, Fabian and Witt, Stephanie H and Herms, Stefan and Hoffmann, Per and Heilmann-Heimbach, Stefanie and Opel, Nils and Repple, Jonathan and Jansen, Andreas and Nenadić, Igor and Papiol, Sergi and Heilbronner, Urs and Kalman, Janos L and Schaupp, Sabrina K and Senner, Fanny and Schulte, Eva C and Falkai, Peter G and Schulze, Thomas G and Dannlowski, Udo and Kircher, Tilo and Rietschel, Marcella and Nöthen, Markus M and Krug, Axel and Forstner, Andreas J},
title = {Genetic contributions to transdiagnostic symptom dimensions in patients with major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders},
journal = {Schizophrenia Research},
year = {2023},
volume = {252},
pages = {161--171},
doi = {10.1016/j.schres.2023.01.002}
}
EUVIMED